Promising Genetically-Enhanced Stem Cell Therapy for Pulmonary Arterial Hypertension Discovered

A new study recently published in the journal Circulation Research revealed encouraging results in the world’s first clinical trial using a genetically-enhanced stem cell therapy for pulmonary arterial hypertension (PAH). The study is entitled …

[Read the full article here]

Comments are closed.